Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | FDPS | P14324 | 1/20 | 0.55 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.54 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.54 |
| ▸ | ABAT | P80404 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.52 |
| ▸ | TTR | P02766 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17629454 | 1.00 | FGFR1 (0.65) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL29473914 | 1.00 | FGFR1 (0.65) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| Acetone SCHEMBL2878424 | 0.97 | FGFR1 (0.62) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL13280206 | 0.96 | FGFR1 (0.61) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL30286001 | 0.94 | ALDH1A1 (0.64) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL31053796 | 0.89 | ALDH1A1 (0.62) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL20435068 | 0.89 | ALDH1A1 (0.62) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL20435062 | 0.89 | ALDH1A1 (0.62) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL20435069 | 0.89 | ALDH1A1 (0.62) | FGFR1ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL3277719 | 0.89 | ALDH1A1 (0.62) | FGFR1ALDH1A1TSHRKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1051 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-20250302728-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2025-10-02 | — | — | US | claimed |
| US-20250280857-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZOOMESSENCE INC (US) | 2025-09-11 | — | — | US | claimed |
| EP-4608360-A1 | ANTI-DANDRUFF COMPOSITIONS | Firmenich SA (CH) | 2025-09-03 | — | — | EP | claimed |
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| WO-2025120502-A1 | COMPOSITION OF CELLULOSE ESTER AND PLASTICIZER AND RELATED ARTICLE COMPRISING THE SAME | LUXOTTICA S.R.L. (IT) | 2025-06-12 | — | — | WO | claimed |
| EP-4555060-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | The Procter & Gamble Company (US) | 2025-05-21 | — | — | EP | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| US-20080071238-A1 | Absorbent articles including an improved odor control system | PROCTER & GAMBLE COMPANY, THE | 2008-03-20 | — | — | US | claimed |
| WO-2008018044-A2 | ABSORBENT ARTICLES INCLUDING AN IMPROVED ODOUR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2008-02-14 | — | — | WO | claimed |
| EP-1886698-A1 | Absorbent articles including an improved odour control system | The Procter and Gamble Company (US) | 2008-02-13 | — | — | EP | claimed |
| WO-2007113778-A2 | ABSORBENT ARTICLES INCLUDING ODOUR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-11 | — | — | WO | claimed |
| EP-1842565-A1 | Absorbent articles including odour control system | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-10 | — | — | EP | claimed |
| EP-1842564-A1 | Absorbent articles including odour control system | The Procter and Gamble Company (US) | 2007-10-10 | — | — | EP | claimed |
| US-20070135319-A1 | Multi-phase personal care composition comprising a stabilizing perfume composition | PROCTER & GAMBLE COMPANY, THE | 2007-06-14 | — | — | US | claimed |
| WO-2007052224-A2 | MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2007-05-10 | — | — | WO | claimed |
| CN-1796359-A | Method for synthesizing vanillin ester isobutyric acid through method of acyl chloride | SHANGHAI PERFUME INST (CN) | 2006-07-05 | — | — | CN | claimed |
| CN-1796357-A | Method for synthesizing vanillin ester isobutyric acid through method of acid anhydride | SHANGHAI PERFUME INST (CN) | 2006-07-05 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135319-A1 | Multi-phase personal care composition comprising a stabilizing perfume composition | CUTA, PARG, POLG | FGFR1 4264/4885ALDH1A1 4123/4885TSHR 4509/4885 |
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | FGFR1 3616/4885ALDH1A1 205/4885TSHR 3559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.